Dr Diego Wyszynski | Chief Executive Officer

Dr Diego Wyszynski, Chief Executive Officer, Pregistry

Dr. Wyszynski’s main area of expertise is the assessment of drug and vaccine safety from observational data, with a special emphasis in the analysis of patterns of use and safety of drugs and vaccines during pregnancy. He received his medical degree from the University of Buenos Aires and Master and PhD degrees in Epidemiology from the Johns Hopkins School of Public Health. Dr. Wyszynski is a highly sought-after public speaker and the author of 3 books and more than 90 peer-reviewed medical articles. Before founding Pregistry in 2014, Dr. Wyszynski was Associate Professor of Medicine and of Epidemiology at Boston University and a pharmacovigilance professional for several pharmaceutical companies. Dr. Wyszynski is the Principal Investigator of the ongoing C-VIPER, COVID-PR, and PIPER studies and of many completed studies. He is based in London, England.


WVIC/WAC Day 2 - Nov 30 @ 16:30

Treating COVID-19 in Pregnancy – The COVID-19 International Drug Pregnancy Registry (COVID-PR)

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard


For sponsorship and exhibition opportunities:
Thomas Hall